ArticleOncotarget2024

Comparison of FDG-PET/CT and CT for evaluation of tumor response to nivolumab plus ipilimumab combination therapy and prognosis prediction in patients with unresectable malignant pleural mesothelioma.

Kazuhiro Kitajima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.